NEW HAVEN, Conn., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at three upcoming investor conferences:
- Deutsche Bank 2013 BioFEST on Tuesday, December 3, 2013 at 10:10 a.m. ET at the Four Seasons Hotel Boston in Boston, MA;
- The 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 12:30 p.m. ET at The New York Palace Hotel in New York, NY; and
- Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11, 2013 at 1:35 p.m. ET at the Crowne Plaza Times Square in New York, NY.
CONTACT: Company Contact: Glenn Schulman Achillion Pharmaceuticals, Inc. Tel. (203) 752-5510 firstname.lastname@example.org Investors: Mary Kay Fenton Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 email@example.com